Tactical US stock recommendations selected from America’s most dominant large cap companies. These ideas focus on earnings triggers, price momentum and sector leadership within highly liquid global names. Built for investors seeking short term opportunities in US markets with defined entry, target and disciplined exit strategy over a 3 month horizon.
“US Stocks to Buy for 3 Months” is a tactical recommendation category that identifies high-quality US equities that are positioned for performance over the next 90 days. These are not random picks; they are US shares selected through rigorous scientific criteria that combine business fundamentals, sector strength, and near-term technical momentum. Whether it’s a tech leader, consumer disruptor, or healthcare innovator, this category helps you participate in the broader US stock market movement.
This category is ideal for Indian investors who are new to international investing but want a structured way to explore the US markets without long-term commitment. If you have some exposure to domestic markets and want to diversify globally especially into best US stocks to buy in a medium horizon this category makes entry smoother and more systematic.
The US stock market hosts some of the world’s most successful and innovative companies, such as those in the S&P 500 and Nasdaq. These firms often outperform due to strong earnings growth, global reach, and dominant market positions. By using a rules-based process that evaluates financial health and trend confirmation, this category seeks to identify stocks that are more likely to capture positive price action over the next 3 months, without relying on speculation.
Positions in this category are intended to be held for approximately three months. This balance ensures that your capital works meaningfully while avoiding unnecessary churn, a key advantage for busy investors
Unlike “long-term buy and hold” portfolios, this category blends disciplined research with a defined time frame. It allows Indian investors to gain exposure to the US stock market today and benefit from global trends without committing their capital for years. With each recommendation backed by data not tips you get a scientific pathway into US equity investing.
Live Open Trade Recommendations
Unlock all Recommendations - Start your Free Trial
Get instant access to live calls Entry, Target, Stoploss and auto-tracked performance.
Closed Recommendations
FAQ’s
We select from recommendations from S&P 500 and Nasdaq 100, focusing on liquid, fundamentally strong companies across sectors
You can expect 6-8 recommendations per month, depending on market opportunities and the availability of high-conviction setups.
We recommend allocating around 4–5% of your US equity capital per stock to maintain diversification and manage risk effectively.
The maximum stoploss is typically in the range of 10–12%, depending on the volatility and structure of the stock.
Each stock is intended to be held for approximately three months. However, some stocks can be held for longer than 3 months if they are in winning position while we may cut our losers earlier than 3 months too.
Yes, this category is suitable for beginners who wants structured exposure to US markets with a defined time horizon and disciplined risk management.
Disclaimer
The analyst certifies that all of the views expressed reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The views provided herein are general in nature and do not consider risk appetite or investment objective of any particular investor; readers are requested to take independent professional advice before investing.
Research analyst or his/her relative or Samco Securities’s associates may have long / short positions, financial interest in the subject company or may have interests/ positions, financial or otherwise in the Securities/Currencies and other investment products mentioned.
Samco Securities or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report / public appearance.
Samco Securities, its associates, directors, employees, research analyst (including relatives) may be engaged in any transaction involving such Securities, earn brokerage or compensation or act as a market maker/advisor/lender/borrower to such company(ies) or have other potential/material conflict of interest with respect to any recommendation at the time of public appearance.
For detailed disclaimer, please visit: https://www.samco.in/disclaimer




Easy & quick